Xxneaxxphaxxacexxicaxx LXX (nxx) is a pharmaceutical importer and buyer based in the United States, specializing in the acquisition of finished pharmaceutical formulations from international markets, particularly India. The company operates as a key player in the U.S. pharmaceutical distribution network, sourcing a diverse range of medications to meet domestic healthcare needs. While specific details about its headquarters and parent company are not publicly disclosed, nxx's role is pivotal in ensuring the availability of essential pharmaceutical products within the U.S. market.
Between 2022 and 2026, nxx imported a total of $1.1 million worth of pharmaceutical products from India, encompassing 22 shipments. These imports included four distinct products across three therapeutic categories, highlighting the company's strategic focus on sourcing a variety of medications to address multiple health conditions. The top five imported products were Propranolol ($550K), Tramadol ($350K), Sulfamethoxazole ($100K), and Trimethoprim ($100K), collectively accounting for 100% of the company's pharmaceutical imports from India during this period.
